Caribou Biosciences (CRBU) News Today $0.78 -0.02 (-2.64%) Closing price 04:00 PM EasternExtended Trading$0.80 +0.02 (+2.43%) As of 06:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Caribou Biosciences, Inc. (NASDAQ:CRBU) Short Interest Down 13.7% in MarchCaribou Biosciences, Inc. (NASDAQ:CRBU - Get Free Report) saw a large drop in short interest in the month of March. As of March 15th, there was short interest totalling 8,820,000 shares, a drop of 13.7% from the February 28th total of 10,220,000 shares. Currently, 10.9% of the shares of the stock are sold short. Based on an average daily volume of 1,290,000 shares, the days-to-cover ratio is currently 6.8 days.April 4, 2025 | marketbeat.comCaribou Biosciences, Inc. (NASDAQ:CRBU) Receives Consensus Rating of "Buy" from AnalystsCaribou Biosciences, Inc. (NASDAQ:CRBU - Get Free Report) has been given a consensus rating of "Buy" by the five research firms that are presently covering the firm, Marketbeat Ratings reports. Five investment analysts have rated the stock with a buy rating. The average 12-month price target amongMarch 23, 2025 | marketbeat.comWhat is HC Wainwright's Forecast for CRBU Q1 Earnings?Caribou Biosciences, Inc. (NASDAQ:CRBU - Free Report) - Research analysts at HC Wainwright issued their Q1 2025 earnings per share estimates for shares of Caribou Biosciences in a research note issued on Wednesday, March 19th. HC Wainwright analyst R. Burns forecasts that the company will earn ($March 22, 2025 | marketbeat.comCaribou Biosciences (NASDAQ:CRBU) Given Buy Rating at HC WainwrightHC Wainwright reissued a "buy" rating and issued a $9.00 price target on shares of Caribou Biosciences in a research note on Wednesday.March 20, 2025 | marketbeat.comCaribou Biosciences, Inc. (NASDAQ:CRBU) CEO Rachel E. Haurwitz Acquires 20,000 SharesCaribou Biosciences, Inc. (NASDAQ:CRBU - Get Free Report) CEO Rachel E. Haurwitz acquired 20,000 shares of the stock in a transaction that occurred on Friday, March 14th. The stock was acquired at an average cost of $1.02 per share, with a total value of $20,400.00. Following the completion of the purchase, the chief executive officer now owns 3,369,395 shares of the company's stock, valued at $3,436,782.90. This trade represents a 0.60 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.March 18, 2025 | marketbeat.comEvercore ISI Sticks to Their Hold Rating for Caribou Biosciences (CRBU)March 14, 2025 | markets.businessinsider.comBrookline Capital Management Weighs in on CRBU Q1 EarningsCaribou Biosciences, Inc. (NASDAQ:CRBU - Free Report) - Research analysts at Brookline Capital Management issued their Q1 2025 earnings per share (EPS) estimates for Caribou Biosciences in a research report issued on Tuesday, March 11th. Brookline Capital Management analyst L. Cann expects that tMarch 14, 2025 | marketbeat.comFY2029 EPS Estimates for CRBU Decreased by AnalystCaribou Biosciences, Inc. (NASDAQ:CRBU - Free Report) - Equities research analysts at Brookline Capital Management decreased their FY2029 earnings per share estimates for Caribou Biosciences in a research report issued to clients and investors on Tuesday, March 11th. Brookline Capital ManagementMarch 13, 2025 | marketbeat.comCaribou Biosciences, Inc.: Caribou Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business UpdateMarch 12, 2025 | finanznachrichten.deCaribou Biosciences Advances CRISPR Therapies Amid Financial ChallengesMarch 12, 2025 | tipranks.comCaribou Biosciences (NASDAQ:CRBU) Announces Earnings Results, Beats Expectations By $0.01 EPSCaribou Biosciences (NASDAQ:CRBU - Get Free Report) issued its quarterly earnings results on Monday. The company reported ($0.39) earnings per share for the quarter, topping analysts' consensus estimates of ($0.40) by $0.01. Caribou Biosciences had a negative return on equity of 45.46% and a negative net margin of 1,290.81%.March 11, 2025 | marketbeat.comCaribou Biosciences reports Q4 EPS (39c), consensus (42c)March 10, 2025 | markets.businessinsider.comCaribou Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business UpdateMarch 10, 2025 | globenewswire.comCARIBOU ALERT: Bragar Eagel & Squire, P.C. is Investigating Caribou Biosciences, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmMarch 6, 2025 | globenewswire.comCaribou Biosciences (CRBU) Expected to Announce Quarterly Earnings on MondayCaribou Biosciences (NASDAQ:CRBU) will be releasing earnings before the market opens on Monday, March 10, Financial Modeling Prep reports.March 3, 2025 | marketbeat.comCaribou Biosciences, Inc. (NASDAQ:CRBU) Receives Consensus Recommendation of "Buy" from AnalystsCaribou Biosciences, Inc. (NASDAQ:CRBU - Get Free Report) has received an average recommendation of "Buy" from the five research firms that are presently covering the stock, MarketBeat Ratings reports. Five analysts have rated the stock with a buy recommendation. The average twelve-month price objFebruary 26, 2025 | marketbeat.comCaribou Biosciences, Inc. (NASDAQ:CRBU) is a favorite amongst institutional investors who own 62%February 25, 2025 | finance.yahoo.comCRBU Deadline: CRBU Investors Have Opportunity to Lead Caribou Biosciences, Inc. Securities Fraud LawsuitFebruary 24, 2025 | prnewswire.comCaribou Biosciences, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses; February 24, 2025 Deadline to file Lead Plaintiff MotionFebruary 24, 2025 | globenewswire.comLevi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Caribou Biosciences, Inc. (CRBU) ShareholdersFebruary 24, 2025 | globenewswire.comShareholders of Caribou Biosciences, Inc. ...February 24, 2025 | gurufocus.comShareholders of Caribou Biosciences, Inc. Should Contact The Gross Law Firm Before February 24, 2025 to Discuss Your Rights - CRBUFebruary 24, 2025 | prnewswire.comFINAL CRBU DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Caribou Biosciences, Inc. Investors to Join the Class Action LawsuitFebruary 23, 2025 | investing.comCRBU DEADLINE ALERT: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Caribou Biosciences, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important February 24 Deadline inFebruary 23, 2025 | investing.comCRBU DEADLINE NOTICE: ROSEN, NATIONAL TRIAL COUNSEL, Encourages Caribou Biosciences, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important February 24 Deadline in Securities Class Action – CRBUFebruary 22, 2025 | globenewswire.comFebruary 24, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against CRBUFebruary 21, 2025 | prnewswire.comThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of February 24, 2025 in Caribou Biosciences, Inc. Lawsuit – CRBUFebruary 20, 2025 | globenewswire.comFaruqi & Faruqi Reminds Caribou Biosciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 24, 2025 - CRBUFebruary 20, 2025 | prnewswire.comCaribou Biosciences, Inc. Class Action: The Gross Law Firm Reminds Caribou Biosciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 24, 2025 - CRBUFebruary 20, 2025 | prnewswire.comCRBU Deadline: CRBU Investors Have Opportunity to Lead Caribou Biosciences, Inc. Securities Fraud LawsuitFebruary 19, 2025 | prnewswire.comCRBU INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Caribou Biosciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitFebruary 19, 2025 | globenewswire.comCRBU DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Caribou Biosciences, Inc. Investors to Secure Counsel Before Important February 24 Deadline in Securities Class Action - CRBUFebruary 19, 2025 | globenewswire.comSHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Caribou BiosciencesFebruary 19, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Caribou Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadlines - CRBUFebruary 18, 2025 | prnewswire.comCaribou Biosciences to Participate in Upcoming Investor ConferencesFebruary 18, 2025 | globenewswire.comCaribou Biosciences, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before February 24, 2025 to Discuss Your Rights – CRBUFebruary 18, 2025 | globenewswire.comShareholders of Caribou Biosciences, Inc. Should Contact Levi & Korsinsky Before February 24, 2025 to Discuss Your Rights - CRBUFebruary 18, 2025 | prnewswire.comCRBU DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Caribou Biosciences, Inc. Investors to Secure Counsel Before Important February 24 Deadline in Securities Class Action - CRBUFebruary 17, 2025 | investing.comCRBU DEADLINE NOTICE: ROSEN, A TOP RANKED LAW FIRM, Encourages Caribou Biosciences, Inc. Investors to Secure Counsel Before Important February 24 Deadline in Securities Class Action - CRBUFebruary 16, 2025 | investing.comCRBU IMPORTANT DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Caribou Biosciences, Inc. ...February 16, 2025 | gurufocus.comCRBU IMPORTANT DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Caribou Biosciences, Inc. Investors to Secure Counsel Before Important February 24 Deadline in Securities Class Action - CRBUFebruary 16, 2025 | globenewswire.comCRBU Deadline: Rosen Law Firm Urges Caribou Biosciences, Inc. ...February 15, 2025 | gurufocus.comCRBU Deadline: Rosen Law Firm Urges Caribou Biosciences, Inc. (NASDAQ: CRBU) Investors to Contact the Firm for Information About Their RightsFebruary 15, 2025 | businesswire.comCaribou Biosciences, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. February 24, 2025 Deadline to file Lead Plaintiff Motion.February 14, 2025 | globenewswire.comCRBU Deadline: CRBU Investors Have Opportunity to Lead Caribou Biosciences, Inc. Securities Fraud LawsuitFebruary 14, 2025 | prnewswire.comClass Action Filed Against Caribou Biosciences, Inc. (CRBU) - February 24, 2025 Deadline to Join - Contact Levi & KorsinskyFebruary 14, 2025 | prnewswire.comCRBU INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Caribou Biosciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitFebruary 13, 2025 | globenewswire.comCaribou Biosciences, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before February 24, 2025 to Discuss Your Rights – CRBUFebruary 13, 2025 | globenewswire.comCaribou Biosciences, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before February 24, 2025 to Discuss Your Rights - CRBUFebruary 13, 2025 | prnewswire.comClass Action Filed Against Caribou Biosciences, Inc. (CRBU) - February 24, 2025 Deadline to Join – Contact The Gross Law FirmFebruary 12, 2025 | globenewswire.com Remove Ads Get Caribou Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for CRBU and its competitors with MarketBeat's FREE daily newsletter. Email Address CRBU Media Mentions By Week CRBU Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CRBU News Sentiment▼0.470.78▲Average Medical News Sentiment CRBU News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CRBU Articles This Week▼14▲CRBU Articles Average Week Remove Ads Get Caribou Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for CRBU and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Aura Biosciences News Today Cryoport News Today Cartesian Therapeutics News Today 2seventy bio News Today Aquestive Therapeutics News Today Taysha Gene Therapies News Today Astria Therapeutics News Today Atyr PHARMA News Today Atai Life Sciences News Today COMPASS Pathways News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CRBU) was last updated on 4/15/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Caribou Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Caribou Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CRBU Stock Free CRBU Stock Alerts